{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/32.1-73.23.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/32.1-73.23.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/32.1-73.23.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/32.1-73.23.html"}],"law_id":82517,"edition_id":1,"section_id":82517,"structure_id":14667,"section_number":"32.1-73.23","catch_line":"Collection of sickle cell disease case information by the Commissioner","history":"2024, c. 437.","full_text":"A\n\nUsing such funds as may be appropriated therefor, the Commissioner or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices required to report information on such patients pursuant to the reporting requirements of § 32.1-73.22 in order to ensure the completeness and accuracy of the statewide sickle cell disease registry.B\n\nThe selection criteria for determining which consenting hospitals, clinics, independent pathology laboratories, and physician offices may be subject to on-site data collection under the provisions of this section shall include (i) the expected annual number of sickle cell disease case reports from each such facility, (ii) the historical completeness and accuracy of reporting rates of each facility under consideration, and (iii) whether the facility maintains its own sickle cell disease registry.C\n\nThe Board shall promulgate regulations necessary to implement the provisions of this section.","order_by":null,"text":{"0":{"id":295623,"text":"Using such funds as may be appropriated therefor, the Commissioner or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices required to report information on such patients pursuant to the reporting requirements of § 32.1-73.22 in order to ensure the completeness and accuracy of the statewide sickle cell disease registry.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":295624,"text":"The selection criteria for determining which consenting hospitals, clinics, independent pathology laboratories, and physician offices may be subject to on-site data collection under the provisions of this section shall include (i) the expected annual number of sickle cell disease case reports from each such facility, (ii) the historical completeness and accuracy of reporting rates of each facility under consideration, and (iii) whether the facility maintains its own sickle cell disease registry.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"C"},"2":{"id":295625,"text":"The Board shall promulgate regulations necessary to implement the provisions of this section.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B"}},"ancestry":[{"id":14667,"edition_id":1,"name":"Statewide Sickle Cell Disease Registry","identifier":"22","label":"article","depth":3,"order_by":1,"parent_id":13607,"metadata":{},"date_created":"2026-06-26 03:49:14","date_modified":"2026-06-26 03:49:14","permalink":{"id":201901,"object_type":"structure","relational_id":14667,"identifier":"22","token":"32.1\/2\/22","url":"\/32.1\/2\/22\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13607,"edition_id":1,"name":"Disease Prevention and Control","identifier":"2","label":"chapter","depth":2,"order_by":1,"parent_id":12727,"metadata":{},"date_created":"2026-06-26 03:45:22","date_modified":"2026-06-26 03:45:22","permalink":{"id":201743,"object_type":"structure","relational_id":13607,"identifier":"2","token":"32.1\/2","url":"\/32.1\/2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12727,"edition_id":1,"name":"Health","identifier":"32.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:50","date_modified":"2026-06-26 03:43:50","permalink":{"id":201099,"object_type":"structure","relational_id":12727,"identifier":"32.1","token":"32.1","url":"\/32.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":56263,"structure_id":14667,"section_number":"32.1-73.22","catch_line":"Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry","url":"\/32.1-73.22\/","token":"32.1\/2\/22\/32.1-73.22","metadata":false},{"id":82517,"structure_id":14667,"section_number":"32.1-73.23","catch_line":"Collection of sickle cell disease case information by the Commissioner","url":"\/32.1-73.23\/","token":"32.1\/2\/22\/32.1-73.23","metadata":false},{"id":68156,"structure_id":14667,"section_number":"32.1-73.24","catch_line":"Confidential nature of information supplied; publication; reciprocal data-sharing agreements","url":"\/32.1-73.24\/","token":"32.1\/2\/22\/32.1-73.24","metadata":false},{"id":78812,"structure_id":14667,"section_number":"32.1-73.25","catch_line":"Penalties for unauthorized use of statewide sickle cell disease registry","url":"\/32.1-73.25\/","token":"32.1\/2\/22\/32.1-73.25","metadata":false},{"id":76725,"structure_id":14667,"section_number":"32.1-73.26","catch_line":"Notification of sickle cell disease patients of statewide sickle cell disease registry reporting","url":"\/32.1-73.26\/","token":"32.1\/2\/22\/32.1-73.26","metadata":false},{"id":83107,"structure_id":14667,"section_number":"32.1-73.27","catch_line":"Annual report; sickle cell disease registry","url":"\/32.1-73.27\/","token":"32.1\/2\/22\/32.1-73.27","metadata":false}],"previous_section":{"id":56263,"structure_id":14667,"section_number":"32.1-73.22","catch_line":"Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry","url":"\/32.1-73.22\/","token":"32.1\/2\/22\/32.1-73.22","metadata":false},"next_section":{"id":68156,"structure_id":14667,"section_number":"32.1-73.24","catch_line":"Confidential nature of information supplied; publication; reciprocal data-sharing agreements","url":"\/32.1-73.24\/","token":"32.1\/2\/22\/32.1-73.24","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.23\/","history_text":"

This law was first created in 2024. The record of its establishment is cataloged in chapter 437<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year.<\/p>","references":false,"refers_to":[{"id":56263,"section_number":"32.1-73.22","catch_line":"Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry","order_by":null,"url":"\/32.1-73.22\/"}],"permalink":{"id":201907,"object_type":"law","relational_id":82517,"identifier":"32.1-73.23","token":"32.1\/2\/22\/32.1-73.23","url":"\/32.1-73.23\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/32.1-73.23\/","token":"32.1\/2\/22\/32.1-73.23","dublin_core":{"Title":"Collection of sickle cell disease case information by the Commissioner","Type":"Text","Format":"text\/html","Identifier":"\u00a7 32.1-73.23","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> Using such funds as may be appropriated therefor, the Commissioner<\/span> or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices required to report information on such patients pursuant to the reporting requirements of § 32.1-73.22<\/a> in order<\/span> to ensure the completeness and accuracy of the statewide sickle cell disease registry. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> The selection criteria for determining which consenting hospitals, clinics, independent pathology laboratories, and physician offices may be subject to on-site data collection under the provisions of this section shall include (i) the expected annual number of sickle cell disease case reports from each such facility, (ii) the historical completeness and accuracy of reporting rates of each facility under consideration, and (iii) whether the facility maintains its own sickle cell disease registry. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> The Board<\/span> shall promulgate regulations necessary to implement the provisions of this section. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nCOLLECTION OF SICKLE CELL DISEASE CASE INFORMATION BY THE COMMISSIONER (\u00a7\n32.1-73.23)\n\nA. Using such funds as may be appropriated therefor, the Commissioner or his\ndesignee may perform on-site data collection of the records of patients having\nsickle cell disease at those consenting hospitals, clinics, independent\npathology laboratories, and physician offices required to report information on\nsuch patients pursuant to the reporting requirements of § 32.1-73.22 in\norder to ensure the completeness and accuracy of the statewide sickle cell\ndisease registry.\n\nB. The selection criteria for determining which consenting hospitals, clinics,\nindependent pathology laboratories, and physician offices may be subject to\non-site data collection under the provisions of this section shall include (i)\nthe expected annual number of sickle cell disease case reports from each such\nfacility, (ii) the historical completeness and accuracy of reporting rates of\neach facility under consideration, and (iii) whether the facility maintains its\nown sickle cell disease registry.\n\nC. The Board shall promulgate regulations necessary to implement the provisions\nof this section.\n\nHISTORY: 2024, c. 437.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}